| Literature DB >> 34066800 |
Irina Fierascu1,2, Radu Claudiu Fierascu1,3, Camelia Ungureanu4, Oana Alexandra Draghiceanu5, Liliana Cristina Soare5.
Abstract
The area of phytosynthesized nanomaterials is rapidly developing, with numerous studies being published yearly. The use of plant extracts is an alternative method to reduce the toxic potential of the nanomaterials and the interest in obtaining phytosynthesized nanoparticles is usually directed towards accessible and common plant species, ferns not being explored to their real potential in this field. The developed nanoparticles could benefit from their superior antimicrobial and antioxidant properties (compared with the nanoparticles obtained by other routes), thus proposing an important alternative against health care-associated and drug-resistant infections, as well as in other types of applications. The present review aims to summarize the explored application of ferns in nanotechnology and related areas, as well as the current bottlenecks and future perspectives, as emerging from the literature data.Entities:
Keywords: Polypodiopsida; antimicrobial; antioxidant; nanotechnology; phytosynthesis
Year: 2021 PMID: 34066800 PMCID: PMC8151343 DOI: 10.3390/antiox10050748
Source DB: PubMed Journal: Antioxidants (Basel) ISSN: 2076-3921
Figure 1Polypodiopsida species: applications in nanotechnology and related areas to be discussed in the following chapters.
Synthetic classification of the Polypodiopsida class.
| Class | Subclass | Order | Families | Genera | Species |
|---|---|---|---|---|---|
|
|
| 1 | 1 | 1 | 15 |
|
| 2 | 2 | 12 | 129 | |
|
| 1 | 1 | 6 | 111 | |
|
| 7 | 44 | 300 | 10,323 | |
| Extant ferns | 11 | 48 | 319 | 10,578 | |
Figure 2Phytosynthesis process and some of the involved phytoconstituents of ferns.
Some examples on the phytosynthesis of nanoparticles using ferns (presented alphabetically, by the family name; results obtained from the application studies are presented in Section 3.2.).1.
| Fern | Family | Plant Part | Extraction Conditions | NP Characteristics | Intended Application | Ref. |
|---|---|---|---|---|---|---|
|
| ||||||
|
| Leaves, rhizomes | Ethanol, V.M.S.R. = 1:10, 48 h, R.T. | AgNPs, <50 nm | Antioxidant, cytotoxic | [ | |
|
| Leaves | Water:ethanol, V.M.S.R. = 1:10, temperature extraction (2 h, 80 °C), microwave extraction (80 °C | AgNPs, spherical, 12 nm (classical extraction), 10 nm (microwave extraction) | Antimicrobial, cytotoxic, phytotoxic | [ | |
|
| Leaves, powder | Dried powder directly applied in the metallic salt solution | AgNPs, spherical, oval, triangular, 10–45 nm | Photocatalytic, anticoagulative | [ | |
|
| Leaves, powder | Water, V.M.S.R. = 1:4.5, 70 °C, 20 min. | AgNPs, spherical, 10–25 nm (increased with extract concentration) | Antimicrobial | [ | |
|
| Leaves | Water, V.M.S.R. = 1:10, boiling, 5 min. | AgNPs, spherical, 35–65 nm | Mosquitocidal, antiplasmodial | [ | |
|
| Rhizomes | Water, V.M.S.R. = 1:2.5, boiling, 30 min. | AgNPs, spherical, 5–60 nm (pH, extract, metallic salt and light exposure dependant) | Antibacterial | [ | |
|
| Leaves | Water, V.M.S.R. = 1:25, microwave extraction (100 W for 3 min, 180 W for 1 min) | AgNPs, nearly spherical, 10–60 nm (phytosynthesis temperature dependant) | Antimicrobial | [ | |
|
| Leaves | Water, V.M.S.R. = 1:4.58, boiled for 20 min under stirring. | AgNPs, spherical, hydrodynamic diameter, 170.5 nm | Cytotoxicity, antidiabetic, antioxidant, antibacterial | [ | |
|
| Leaves | Water, liquid-solid extraction, V.M.S.R. = 1:10, 80 °C, 3 min | AgNPs, spherical, 20 nm | Coating biodeterioration control | [ | |
|
| Leaves | Water, V.M.S.R. = 1:10, boiled for 5 min. | AgNPs, spherical, 40–60 nm | Mosquito oviposition deterrents | [ | |
|
| Leaves | Powdered sample soaked in methanol for 72 h at RT, with frequent manual agitation. | AgNPs, spherical, 7.51 ± 2.88 nm. | Antimicrobial | [ | |
|
| Leaves | Methanol, V.M.S.R. = 1:8, 50 °C, 10 min. | RuNPs, hexagonal, amorphous, ~26 nm | Antifungal, antioxidant | [ | |
|
| Tubers | Water, V.M.S.R. = 1:10, boiled for 15 min under stirring | Au–Ag@AgCl nanocomposites, spherical, 10–50 nm (average 30 nm) | Nanocatalysts | [ | |
|
| Tubers | Water, V.M.S.R. = 1:20, boiled for 10 min | SiO2@Au–Ag nanocomposites, Spherical SiO2 decorated with AuNPs and AgNPs, 200–246 nm (SiO2), 3 nm (AgNPs/AuNPs) | Nanocatalysts, antibacterial, cytotoxic | [ | |
|
| Not | Water, V.M.S.R. = 3:100, 80 °C for 80 min. | FeNPs, amorphous, spherical 40–70 nm, other iron oxides | Cr (VI) removal | [ | |
|
| Aerial parts | Dried plant material, water, V.M.S.R. = 1:20 | Anisotropic, AgNP, 13 nm, AuNP, 11 nm | Proposed for biomedical applications | [ | |
|
| Aerial parts | Dried plant material, water, V.M.S.R. = 1:50, 25 °C for 72 h., under continuous shaking. | AuNPs, spherical and triangular, average particle size 33.9 ± 14.0 nm. | Antibacterial | [ | |
|
| Whole plant | Dried plant material, water, V.M.S.R. = 1:20 | AgNPs, quasi-spherical, 10–60 nm | Antimicrobial | [ | |
|
| Whole plant | Dried plant material, water, V.M.S.R. = 1:20 | CuONPs, quasi-spherical, 1–20 nm | Plant defence booster | [ | |
|
| Leaves | Water, V.M.S.R. = 1:20, boiling for 5 min. | AgNPs, hexagonal, spherical, and rod-shaped, 32 nm | Anticancer, toxicity studies (on Zebra fish) | [ | |
|
| Leaves | Dried leaf powder, water, V.M.S.R. = 1:10, 3 h., magnetic stirring | AgNPs, mostly spherical, with cubic morphologies, 9.69–13.9 nm | Mosquitocidal | [ | |
|
| Leaves | Dried leaf powder, water, 70 °C, 15 min. | AgNPs, spherical, 18.4 nm | Antibacterial | [ | |
|
| Leaves | Dried leaf powder, water, M.S.R. = 1:10, 60 °C, 10 min. | AuNPs | Antioxidant, antibacterial, antifungal | [ | |
|
| Leaves | Aqueous extract | AgNPs, AuNPs | Anticancer | [ | |
|
| Leaves | Dried leaf powder, water, M.S.R. = 1:10, 60 °C, 10 min. | AuNPs | Antioxidant, antibacterial, antifungal | [ | |
|
| ||||||
|
| Leaves | Water, V.M.S.R. = 1:20, 90 °C, 1 h., under stirring (400 rpm) | AgNPs, spherical, 9–42 nm | Antibacterial, anticancer | [ | |
|
| Leaves | Dried leaf powder, methanol, V.M.S.R. = 1:10, R.T., 72 h. | AuNPs, spherical, 17–40 nm | Antidiabetic | [ | |
|
| Leaves | Dried leaf powder, water, V.M.S.R. = 1:25, 55 °C, 15 min. | AuNPs, spherical, 10–40 nm | Antioxidant, cytotoxic | [ | |
|
| Leaves | Methanol, V.M.S.R. = ~1:6, 24 h., under magnetic stirring | AgNPs | Antioxidant | [ | |
|
| Whole plant | Dried powder, hydroalcoholic solution (70%/96%), percolation (48 h.), V.M.S.R. = 1:2.5 | AgNPs, spherical, average size 6.5 nm | No application proposed | [ | |
|
| In vivo formation | Formation of NPs in root cells | PbNPs, spherical, rod-shaped, 12–80 nm dependent on the formation site | No application proposed | [ | |
|
| Whole plant | Dried powder, methanol, 72 h., V.M.S.R. = 1:10 | AuNPs, spherical, 17–40 nm | Antioxidant, hepatoprotective | [ | |
|
| Whole plant | Dried plant, water, boiling, 5 min., V.M.S.R. = 1:100 | AuNPs, various morphologies: spherical, triangular, pentagonal and nanoflower-like, dimensions ranging from 7 to 175.8 nm, dependent on the part plant used and extract to metallic salt ratio | No application proposed | [ | |
|
| Leaves | Water, boiling, 5 min., V.M.S.R. = 1:5 | AgNPs, spherical, average size 12.46 nm | Antimicrobial | [ | |
|
| ||||||
|
| Roots | Dried powder, water, boiling, 30 min., V.M.S.R. = 1:20 | AgNPs, spherical, 5–40 nm; | Antimicrobial, antioxidant, cytotoxic | [ | |
|
| Sporophytes | Water, boiling, 30 min., V.M.S.R. = 1:10 | AgNPs, spherical, 45–74 nm | Cytotoxic, phytotoxic | [ | |
1 where: R.T.—room temperature, V.M.S.R.—vegetal material to solvent ratio.
Potential applications of nanoparticles phytosynthesized using ferns 1.
| Fern Used | Applied NPs | Application Results | Ref. |
|---|---|---|---|
|
| |||
| AgNPs, 10–12 nm | Evaluated against | [ | |
| AgNPs, spherical, 5–60 nm | Evaluated against | [ | |
| AgNPs, nearly spherical, 10–60 nm | Evaluated against | [ | |
| AgNPs, spherical, 170.5 nm | evaluated against | [ | |
| AgNPs, spherical, 20 nm | Evaluated against | [ | |
| AgNPs, spherical, 40–60 nm | Evaluated against | [ | |
| AgNPs, spherical, 7.51 nm. | Evaluated against | [ | |
| RuNPs, ~26 nm | Evaluated against | [ | |
| SiO2@Au–Ag composites (200–246 nm SiO2 decorated with 3-nm AuNPs/AgNPs) | Evaluated against | [ | |
| AuNPs—spherical, triangular, 33.9 nm in AuNPs–amoxicillin composites | Evaluated against | [ | |
| AgNPs, quasi-spherical, 10–60 nm | Evaluated against | [ | |
| AgNPs, different morphologies, 32 nm | Evaluated against | [ | |
| AgNPs, spherical, 18.4 nm | Evaluated against | [ | |
| AuNPs | Evaluated against | [ | |
| AuNPs | Evaluated against | [ | |
| AgNPs, spherical, 9–42 nm | Evaluated against | [ | |
| AgNPs, spherical, 12.46 nm | Evaluated against | [ | |
| AgNPs, spherical, 5–40 nm; | Evaluated against | [ | |
|
| |||
| AgNPs, < 50 nm | DPPH inhibition 81.34%/80.93% (rhizomes/leaves mediated NPs) | [ | |
| AgNPs, spherical, 170.5 nm | IC0.50 (reducing power activity) = 641.24 μg/mL; IC50 (ABTS/DPPH/NOx) = 210.16/92.90/62.52 μg/mL; | [ | |
| RuNPs, ~26 nm | IC50 (mg/mL, DPPH, ABTS, SORS, HSA assays) = 0.986/0.852/1.265/1.389 | [ | |
| AgNPs, different morphologies, 32 nm | DPPH, chelating activity, Phosphomolybdenum, ABTS, HPSA assays: | [ | |
| AuNPs | Inhibition: | [ | |
| AuNPs | Inhibition: | [ | |
| AuNPs, spherical, 10–40 nm | IC50 (DPPH) = 50 mg/L; | [ | |
| AgNPs | IC₅₀ = 47.0 μg/mL (DPPH)/35.8 μg/mL (HPSA) | [ | |
| AgNPs, spherical, 5–40 nm; | IC50 (DPPH) = 1.4/1.22 mg/mL (AuNPs/AgNPs) | [ | |
|
| |||
| AgNPs, < 50 nm | Rhizomes extract mediated NPs-progressive time-related mitoinhibitory effect; for both NPs—increased frequency and variability of chromosomal aberrations in the | [ | |
| AgNPs, 10–12 nm | Significantly higher frequency of the total aberrant cells compared with the negative control sample in the | [ | |
| AgNPs, nearly spherical, 10–60 nm | MTT assay (MC3T3-E1): Cytotoxic threshold: >2.25/> 4.5 mg L−1, lower for smaller NPs | [ | |
| AgNPs spherical, 170.5 nm | Trypan blue exclusion test (HepG2): 20% viability (at 1 mg/mL) | [ | |
| SiO2@Au–Ag composites (200–246 nm SiO2 decorated with 3 nm AuNPs/AgNPs) | MTT assay (human keratinocyte cells): 95% cell viability at 500 μg/mL | [ | |
| AuNPs-spherical, triangular, 33.9 nm. | MTT assay (L929): 81% viability (AuNPs), 79% viability (AuNPs–amoxicillin composites) | [ | |
| AgNPs, AuNPs | MTT assay: Cytotoxicity against MCF-7 cells at different concentrations (2.5 to 100 μg/mL); non-cytotoxic to HEK293 cells | [ | |
| AgNPs, spherical, 9–42 nm | MTT assay: Cell death: 40.04% (MCF-7)/55.88% (HeLa), with NP sonication | [ | |
| AuNPs, spherical, 17–40 nm | MTT assay (3T3-L1): Cell viability = 71.23% (100 μM) − 84.02% (30μM); glucose uptake = 60.86% | [ | |
| AuNPs, spherical, 10–40 nm | MTT assay: IC50 = 45.88/52.01 mg/L (PA-1/A549) | [ | |
| AgNPs, spherical, 5–40 nm; | MTT assay (RAW264.7 and MCF-7): AuNPs—no cell death at 0.1–10 mg/L; | [ | |
| AgNPs, spherical, 45–74 nm | Hatched shrimps bioassay: LC50 = 869.4 μL/10 mL | [ | |
|
| |||
| AgNPs spherical, 35–65 nm | Against | [ | |
| AgNPs spherical, 40–60 nm | Against | [ | |
| AgNPs, 9.69–13.9 nm | Against mosquito larvae, in laboratory conditions ( | [ | |
|
| |||
| AgNPs, 10–12 nm | NPs led to the reduction of the phytotoxic effect of the extracts in Triticum test | [ | |
| CuONPs, quasi-spherical, 1–20 nm | Effect on | [ | |
| AgNPs, spherical, 45–74 nm | Effect on | [ | |
|
| |||
| AgNPs, spherical, 170.5 nm | IC50 (alpha-glucosidase) = 1.73 μg/mL; | [ | |
|
| |||
| AgNPs, different morphologies, 32 nm | Anti-inflammatory activity Wistar albino adult female rats using the carrageenan-induced paw oedema method = 56.36%, 24 h., 100 mg/kg b.w. | [ | |
|
| |||
| AuNPs, spherical, 17–40 nm | Significant increase in cell viability compared to the acetaminophen group (hepatocytes damage); significant reduction in the levels of LDH and CAT (dose dependent); AuNPs significantly reduced the GOT and GPT levels (50/10%), significantly increased the levels of GSH-Px and SOD (60–70%), drastically reduced the formation of MDA (60%) and ROS generation | [ | |
|
| |||
| AgNPs, different morphologies, 10–45 nm | Degradation of MB and RhB dyes under solar light illumination: complete disappearance of the adsorption peaks after 8 min. | [ | |
| AgNPs—spherical, 10–25 nm; | Degradation of MV 6B, RB, 4-nitro phenol: Ag-98.4/98/96.8%; Au-98.2/98.9/97.3% | [ | |
| Au–Ag@AgCl, average size 30 nm | Synthesis of quinoline derivatives via three component coupling/hydroarylation/dehydrogenation of arylaldehyde, aniline, and phenyl acetylene derivatives; 96% yield for the composite applied, reaction conditions 9h, at reflux | [ | |
| SiO2@Au–Ag composites (200–246 nm SiO2 decorated with 3 nm AuNPs/AgNPs) | Solvent-free amidation of carboxylic acid catalyst: 97% yield for the composite applied, reaction conditions—8 h, 100 °C | [ | |
|
| |||
| FeNPs, spherical, 40–70 nm, other types of iron oxides | Cr(VI) removal: 90.93% | [ | |
1 where: 3T3-L1—adipocyte cell lines; A549—adenocarcinomic human alveolar basal epithelial cells line; AAE—ascorbic acid equivalents; ABTS—azinobis 3-ethylbenzothiazoline-6-sulfonate; b.w.—body weight; CAT—catalase; DPPH—2,2-diphenyl-1-picrylhydrazyl; EDTA—ethylenediaminetetraacetic acid; ER—effective repellence; GOT—glutamate oxalate transaminase; GPT—glutamate pyruvate transaminase; GSH-Px—glutathione peroxidase; HEK293—human embryonic kidney 293 cells; HeLa—human cervical cancer cell line; HepG2—human liver cancer cell line; HPSA—hydrogen peroxide scavenging activity; IC50—concentration required to result in a 50% antioxidant activity; LC50—LC50 lethal concentration that kills 50% of the exposed organisms; LDH—lactate dehydrogenase; HSA—OH– scavenging activity; L929—normal subcutaneous areolar adipose tissue cellular lines; MB—methylene blue; MBC—minimum bactericidal concentration; MC3T3-E1—mouse pre-osteoblast cells; MCBE—minimal concentration values for biofilm eradication; MCF-7—breast cancer cell line; MDA—malondialdehyde; MI—mitotic index; MIC—minimum inhibitory concentration; MP—mitotic phases; MRSA—Methicillin-resistant Staphylococcus aureus; M.V. 6B—Methyl Violet 6B; NOx—nitric oxide; PA-1—human ovarian teratocarcinoma cell line; RAW264.7—macrophage, Abelson murine leukaemia virus transformed cells line; RB—Rose Bengal; RhB—rhodamine B; ROS—reactive oxygen species; RWC—relative water content; SOD—superoxide dismutase; SORS—Superoxide Radical Scavenging; SVI—Seedling Vigour Index.